Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Hypertension
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Hypertension
    TopAbstracts in Hypertension 11/26/2008 - (DGNews)
    Potassium Loss Caused by Thiazides May Explain Higher Risk of Adult Diabetes - (DGNews)
    High Blood Pressure in Doctor's Office May Not Predict Heart Risks - (DGNews)
    TopAbstracts in Hypertension 11/19/2008 - (DGNews)
    Aliskiren Helps Elderly Patients Achieves Blood Pressure Control: Presented at AHA - (DGDispatch)

    News archive

     Recent webcasts/CME - Hypertension
    • Minimizing Cardiovascular Risk in Patients With Dyslipidemia
    • Beta-Blockers in Hypertension - The Con Discussion
      Vaccination: A New Approach to RAAS Inhibition?
      Beta-Blockers in Hypertension - The Pro Discussion
      Which Anti-RAAS Shall We Use?

      Webcasts/CME archive

       Recent cases - Hypertension
        Aortic Dissection Type I in a Weightlifter with Hypertension: A Case Report
        Transient Left Ventricular Apical Ballooning and Exercise Induced Hypertension During Treadmill Exercise Testing: Is There a Common Hypersympathetic Mechanism?
        Dilation of Renal Artery Stenosis after Administration of Losartan
        Angioedema of the Tongue
        Primary Aldosteronism Caused by a Unilateral Adrenal Adenoma Accompanied by Autonomous Cortisol Secretion

        Cases archive
          




        my personal edition > hypertension > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Pravastatin Therapy May Help Protect Kidney Function In Patients With Well-Controlled Hypertension

        A DGReview of :"Effect of pravastatin on proteinuria in patients with well-controlled hypertension"
        Hypertension

        07/25/2002
        By Andrew A. Skolnick


        The addition of pravastatin to the treatment of well-controlled hypertension may reduce proteinuria and help protect patient kidney function.

        Proteinuria is an important risk factor for cardiovascular and renal morbidity and mortality, say T.M. Lee and colleagues at the National Taiwan University Hospital, in Taipei, Taiwan, who conducted a clinical study of 63 proteinuric patients with well-controlled blood pressure.

        The patients were randomized to receive either pravastatin or placebo, following a three-month placebo period. All patients had well-controlled blood pressure (less than 140/90 mmHg), relatively normal serum cholesterol (less than 240 mg/dl), and proteinuria (300 to 3000 mg/d).

        Proteinuria in patients receiving pravastatin dropped 54 percent after six months, the researchers reported. Creatinine clearance was stable in both groups throughout the study. Despite unchanged plasma endothelin-1 levels, urinary excretion of the peptide decreased and was significantly correlated with improvement in urinary protein excretion in pravastatin-treated patients. The urinary excretion of retinol-binding protein decreased after pravastatin administration, probably reflecting an improvement in tubular function, the investigators said.

        In contrast, urinary excretion of immunoglobulin G did not change significantly throughout the study in either group. Multivariate analysis showed that proteinuria was only significantly correlated with statin use. Linear regression analysis in the statin-treated group did not show any correlation between changes in lipid profiles and proteinuria regression.

        "Thus, in addition to their primary function of antilipidemia, the addition of pravastatin to treatment for well-controlled hypertension may have an additive effect on reducing proteinuria independent of haemodynamics and lipid-lowering effects, possibly through inhibiting renal endothelin-1 synthesis and improving tubular function," the researchers concluded.
        Hypertension 2002; 40: 67-73. "Effect of pravastatin on proteinuria in patients with well-controlled hypertension"

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send